These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 9530563)

  • 1. Therapeutic antibody technology 97.
    Larrick JW; Gavilondo J
    Immunotechnology; 1998 Jan; 3(4):303-7. PubMed ID: 9530563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibody Engineering & Therapeutics 2016: The Antibody Society's annual meeting, December 11-15, 2016, San Diego, CA.
    Larrick JW; Alfenito MR; Scott JK; Parren PW; Burton DR; Bradbury AR; Lemere CA; Messer A; Huston JS; Carter PJ; Veldman T; Chester KA; Schuurman J; Adams GP; Reichert JM
    MAbs; 2016; 8(8):1425-1434. PubMed ID: 27557809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody engineering and therapeutics conference. The annual meeting of the antibody society, Huntington Beach, CA, December 7-11, 2014.
    Larrick JW; Parren P; Huston JS; Plückthun A; Bradbury A; Tomlinson IM; Chester KA; Burton DR; Adams GP; Weiner LM; Scott JK; Alfenito MR; Veldman T; Reichert JM
    MAbs; 2014; 6(5):1115-23. PubMed ID: 25517297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered antibodies take center stage.
    Huston JS; George AJ
    Hum Antibodies; 2001; 10(3-4):127-42. PubMed ID: 11847424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody Engineering & Therapeutics 2015: The Antibody Society's annual meeting December 7-10, 2015, San Diego, CA.
    Parren PW; Burton DR; Bradbury A; Huston JS; Carter PJ; Veldman T; Chester KA; Larrick JW; Alfenito MR; Scott JK; Weiner LM; Adams GP; Reichert JM
    MAbs; 2015; 7(6):981-8. PubMed ID: 26421752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IBC's 23rd Antibody Engineering and 10th Antibody Therapeutics Conferences and the Annual Meeting of The Antibody Society: December 2-6, 2012, San Diego, CA.
    Marquardt J; Begent RH; Chester K; Huston JS; Bradbury A; Scott JK; Thorpe PE; Veldman T; Reichert JM; Weiner LM
    MAbs; 2012; 4(6):648-52. PubMed ID: 23007482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From the History of the Croatian Dermatovenereological Society - The Croatian Medical Association and an Overview of Important Information Regarding the Journal Acta Dermatovenerologica Croatica.
    Dobrić I
    Acta Dermatovenerol Croat; 2018 Dec; 26(4):344-348. PubMed ID: 30665489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proceedings of the Second Workshop on Theory meets Industry (Erwin-Schrödinger-Institute (ESI), Vienna, Austria, 12-14 June 2007).
    Hafner J
    J Phys Condens Matter; 2008 Feb; 20(6):060301. PubMed ID: 21693862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody engineering and therapeutics, The Annual Meeting of the Antibody Society: December 8-12, 2013, Huntington Beach, CA.
    Almagro JC; Gilliland GL; Breden F; Scott JK; Sok D; Pauthner M; Reichert JM; Helguera G; Andrabi R; Mabry R; Bléry M; Voss JE; Laurén J; Abuqayyas L; Barghorn S; Ben-Jacob E; Crowe JE; Huston JS; Johnston SA; Krauland E; Lund-Johansen F; Marasco WA; Parren PW; Xu KY
    MAbs; 2014; 6(3):577-618. PubMed ID: 24589717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The XXIIIrd Phage/Virus Assembly Meeting.
    Serwer P
    Bacteriophage; 2014 Jan; 4(1):e27272. PubMed ID: 24498537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 9th annual European Antibody Congress, November 11-13, 2013, Geneva, Switzerland.
    Reichert JM; Beck A; Lugovskoy AA; Wurch T; Coats S; Brezski RJ
    MAbs; 2014; 6(2):309-26. PubMed ID: 24492298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of antibody drug conjugates: bioanalytical methods and monitoring strategy for a novel therapeutic modality.
    Hock MB; Thudium KE; Carrasco-Triguero M; Schwabe NF
    AAPS J; 2015 Jan; 17(1):35-43. PubMed ID: 25380723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YoungMito 2018: Report on the 1st International Mitochondria Meeting for Young Scientists.
    Yamano K; Lazarou M
    Genes Cells; 2018 Oct; 23(10):822-827. PubMed ID: 30273445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meeting report from the 'Therapeutic Antibody Technology 95' meeting--not just 'another recombinant antibody meeting'.
    Larrick JW; Gavilondo J
    Immunotechnology; 1996 Feb; 2(1):59-63. PubMed ID: 9373328
    [No Abstract]   [Full Text] [Related]  

  • 15. Engineering antibodies for clinical applications.
    Jain M; Kamal N; Batra SK
    Trends Biotechnol; 2007 Jul; 25(7):307-16. PubMed ID: 17512622
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody discovery: phage display.
    Kretzschmar T; von Rüden T
    Curr Opin Biotechnol; 2002 Dec; 13(6):598-602. PubMed ID: 12482520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The biotechnology and applications of antibody engineering.
    Rapley R
    Mol Biotechnol; 1995 Apr; 3(2):139-54. PubMed ID: 7620975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthetic antibodies as therapeutics.
    Fuh G
    Expert Opin Biol Ther; 2007 Jan; 7(1):73-87. PubMed ID: 17150020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The origin of enantioselectivity in aldolase antibodies: crystal structure, site-directed mutagenesis, and computational analysis.
    Zhu X; Tanaka F; Hu Y; Heine A; Fuller R; Zhong G; Olson AJ; Lerner RA; Barbas CF; Wilson IA
    J Mol Biol; 2004 Nov; 343(5):1269-80. PubMed ID: 15491612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Artificial antibodies and enzymes: mimicking nature and beyond.
    Holliger P; Hoogenboom HR
    Trends Biotechnol; 1995 Jan; 13(1):7-9. PubMed ID: 7765803
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.